Model,Temperature,Q_Short,Mean,Median,Mode,Range,Standard Deviation
gpt-3.5-turbo,0.0,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.0,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.0,European market revenue,0.1,0.1,0.1,0.0,0.0
gpt-3.5-turbo,0.0,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.0,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.0,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.0,Maximum annual interest rate,0.08,0.08,0.08,0.0,0.0
gpt-3.5-turbo,0.0,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.0,Minimum ROI,0.24,0.2,0.2,0.09999999999999998,0.0547722557505166
gpt-3.5-turbo,0.0,Minimum revenue increase,0.05,0.05,0.05,0.0,0.0
gpt-3.5-turbo,0.0,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.0,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.0,Potential market share,0.28,0.28,0.28,0.0,0.0
gpt-3.5-turbo,0.0,Potential net profit growth,0.1,0.1,0.1,0.0,0.0
gpt-3.5-turbo,0.0,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.0,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.0,Talent development strategy,0.888888888888889,0.8888888888888888,0.8888888888888888,0.0,1.2412670766236366e-16
gpt-3.5-turbo,0.0,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.0,Workforce increase for S&M,0.25,0.25,0.25,0.0,0.0
gpt-3.5-turbo,0.1,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.1,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.1,European market revenue,0.12000000000000002,0.1,0.1,0.1,0.044721359549995794
gpt-3.5-turbo,0.1,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.1,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.1,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.1,Maximum annual interest rate,0.088,0.08,0.08,0.020000000000000004,0.010954451150103324
gpt-3.5-turbo,0.1,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.1,Minimum ROI,0.24,0.2,0.2,0.09999999999999998,0.0547722557505166
gpt-3.5-turbo,0.1,Minimum revenue increase,0.05,0.05,0.05,0.0,0.0
gpt-3.5-turbo,0.1,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.1,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.1,Potential market share,0.28,0.28,0.28,0.0,0.0
gpt-3.5-turbo,0.1,Potential net profit growth,0.1,0.1,0.1,0.0,0.0
gpt-3.5-turbo,0.1,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.1,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.1,Talent development strategy,0.888888888888889,0.8888888888888888,0.8888888888888888,0.0,1.2412670766236366e-16
gpt-3.5-turbo,0.1,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.1,Workforce increase for S&M,0.25,0.25,0.25,0.0,0.0
gpt-3.5-turbo,0.2,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.2,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.2,European market revenue,0.18,0.2,0.2,0.1,0.044721359549995794
gpt-3.5-turbo,0.2,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.2,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.2,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.2,Maximum annual interest rate,0.092,0.1,0.1,0.020000000000000004,0.010954451150103324
gpt-3.5-turbo,0.2,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.2,Minimum ROI,0.22000000000000003,0.2,0.2,0.09999999999999998,0.04472135954999579
gpt-3.5-turbo,0.2,Minimum revenue increase,0.05,0.05,0.05,0.0,0.0
gpt-3.5-turbo,0.2,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.2,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.2,Potential market share,0.28400000000000003,0.28,0.28,0.019999999999999962,0.008944271909999142
gpt-3.5-turbo,0.2,Potential net profit growth,0.1,0.1,0.1,0.0,0.0
gpt-3.5-turbo,0.2,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.2,Strategic priority,0.2,0.0,0.0,0.5,0.2738612787525831
gpt-3.5-turbo,0.2,Talent development strategy,0.888888888888889,0.8888888888888888,0.8888888888888888,0.0,1.2412670766236366e-16
gpt-3.5-turbo,0.2,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.2,Workforce increase for S&M,0.266,0.25,0.25,0.08000000000000002,0.03577708763999664
gpt-3.5-turbo,0.3,Competitive positioning,0.7,0.75,0.75,0.25,0.11180339887498948
gpt-3.5-turbo,0.3,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.3,European market revenue,0.126,0.1,0.1,0.1,0.0433589667773576
gpt-3.5-turbo,0.3,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.3,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.3,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.3,Maximum annual interest rate,0.08,0.08,0.08,0.04000000000000001,0.014142135623730954
gpt-3.5-turbo,0.3,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.3,Minimum ROI,0.22000000000000003,0.2,0.2,0.09999999999999998,0.04472135954999579
gpt-3.5-turbo,0.3,Minimum revenue increase,0.05,0.05,0.05,0.0,0.0
gpt-3.5-turbo,0.3,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.3,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.3,Potential market share,0.28,0.28,0.28,0.03999999999999998,0.014142135623730944
gpt-3.5-turbo,0.3,Potential net profit growth,0.10400000000000001,0.1,0.1,0.01999999999999999,0.008944271909999153
gpt-3.5-turbo,0.3,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.3,Strategic priority,0.3,0.5,0.5,0.5,0.2738612787525831
gpt-3.5-turbo,0.3,Talent development strategy,0.888888888888889,0.8888888888888888,0.8888888888888888,0.0,1.2412670766236366e-16
gpt-3.5-turbo,0.3,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.3,Workforce increase for S&M,0.28200000000000003,0.25,0.25,0.08000000000000002,0.043817804600413304
gpt-3.5-turbo,0.4,Competitive positioning,0.6,0.5,0.5,0.25,0.13693063937629152
gpt-3.5-turbo,0.4,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.4,European market revenue,0.134,0.13,0.1,0.1,0.040987803063838396
gpt-3.5-turbo,0.4,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.4,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.4,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.4,Maximum annual interest rate,0.078,0.08,0.08,0.04000000000000001,0.014832396974191328
gpt-3.5-turbo,0.4,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.4,Minimum ROI,0.22999999999999998,0.2,0.2,0.09999999999999998,0.04472135954999579
gpt-3.5-turbo,0.4,Minimum revenue increase,0.05,0.05,0.05,0.0,0.0
gpt-3.5-turbo,0.4,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.4,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.4,Potential market share,0.27999999999999997,0.28,0.28,0.04999999999999999,0.0187082869338697
gpt-3.5-turbo,0.4,Potential net profit growth,0.11200000000000002,0.12,0.12,0.01999999999999999,0.010954451150103317
gpt-3.5-turbo,0.4,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.4,Strategic priority,0.1,0.0,0.0,0.5,0.223606797749979
gpt-3.5-turbo,0.4,Talent development strategy,0.888888888888889,0.8888888888888888,0.8888888888888888,0.0,1.2412670766236366e-16
gpt-3.5-turbo,0.4,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.4,Workforce increase for S&M,0.248,0.25,0.25,0.010000000000000009,0.004472135954999583
gpt-3.5-turbo,0.5,Competitive positioning,0.7,0.75,0.75,0.25,0.11180339887498948
gpt-3.5-turbo,0.5,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.5,European market revenue,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.5,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.5,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.5,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.5,Maximum annual interest rate,0.094,0.1,0.1,0.020000000000000004,0.008944271909999161
gpt-3.5-turbo,0.5,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.5,Minimum ROI,0.22000000000000003,0.2,0.2,0.09999999999999998,0.04472135954999579
gpt-3.5-turbo,0.5,Minimum revenue increase,0.05600000000000001,0.05,0.05,0.03,0.013416407864998738
gpt-3.5-turbo,0.5,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.5,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.5,Potential market share,0.284,0.28,0.27,0.02999999999999997,0.015165750888103085
gpt-3.5-turbo,0.5,Potential net profit growth,0.11599999999999999,0.12,0.12,0.01999999999999999,0.008944271909999154
gpt-3.5-turbo,0.5,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.5,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.5,Talent development strategy,0.888888888888889,0.8888888888888888,0.8888888888888888,0.0,1.2412670766236366e-16
gpt-3.5-turbo,0.5,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.5,Workforce increase for S&M,0.28200000000000003,0.25,0.25,0.08000000000000002,0.043817804600413304
gpt-3.5-turbo,0.6,Competitive positioning,0.6,0.5,0.5,0.25,0.13693063937629152
gpt-3.5-turbo,0.6,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.6,European market revenue,0.11800000000000002,0.13,0.13,0.03,0.016431676725154984
gpt-3.5-turbo,0.6,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.6,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.6,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.6,Maximum annual interest rate,0.092,0.1,0.1,0.06,0.02280350850198276
gpt-3.5-turbo,0.6,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.6,Minimum ROI,0.25,0.25,0.2,0.09999999999999998,0.04999999999999999
gpt-3.5-turbo,0.6,Minimum revenue increase,0.076,0.08,0.05,0.05,0.025099800796022267
gpt-3.5-turbo,0.6,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.6,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.6,Potential market share,0.264,0.26,0.26,0.030000000000000027,0.01140175425099139
gpt-3.5-turbo,0.6,Potential net profit growth,0.1,0.1,0.1,0.0,0.0
gpt-3.5-turbo,0.6,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.6,Strategic priority,0.1,0.0,0.0,0.5,0.22360679774997902
gpt-3.5-turbo,0.6,Talent development strategy,0.888888888888889,0.8888888888888888,0.8888888888888888,0.0,1.2412670766236366e-16
gpt-3.5-turbo,0.6,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.6,Workforce increase for S&M,0.31,0.3,0.25,0.16999999999999998,0.07035623639735145
gpt-3.5-turbo,0.7,Competitive positioning,0.65,0.75,0.75,0.25,0.13693063937629152
gpt-3.5-turbo,0.7,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.7,European market revenue,0.10666,0.1,0.1,0.033299999999999996,0.014892212730148598
gpt-3.5-turbo,0.7,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.7,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.7,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.7,Maximum annual interest rate,0.1,0.1,0.08,0.039999999999999994,0.019999999999999997
gpt-3.5-turbo,0.7,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.7,Minimum ROI,0.22000000000000003,0.2,0.2,0.19999999999999998,0.08366600265340754
gpt-3.5-turbo,0.7,Minimum revenue increase,0.12,0.15,0.15,0.09999999999999999,0.04472135954999579
gpt-3.5-turbo,0.7,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.7,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.7,Potential market share,0.264,0.25,0.25,0.04999999999999999,0.02190890230020664
gpt-3.5-turbo,0.7,Potential net profit growth,0.10800000000000001,0.1,0.1,0.01999999999999999,0.010954451150103317
gpt-3.5-turbo,0.7,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.7,Strategic priority,0.4,0.5,0.5,0.5,0.22360679774997902
gpt-3.5-turbo,0.7,Talent development strategy,0.8444444444444444,0.8888888888888888,0.8888888888888888,0.11111111111111105,0.06085806194501842
gpt-3.5-turbo,0.7,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.7,Workforce increase for S&M,0.244,0.25,0.25,0.08000000000000002,0.02880972058177587
gpt-3.5-turbo,0.8,Competitive positioning,0.65,0.75,0.75,0.25,0.13693063937629152
gpt-3.5-turbo,0.8,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.8,European market revenue,0.15,0.13,0.2,0.1,0.046904157598234304
gpt-3.5-turbo,0.8,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.8,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.8,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.8,Maximum annual interest rate,0.096,0.08,0.08,0.06,0.027018512172212593
gpt-3.5-turbo,0.8,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.8,Minimum ROI,0.22000000000000003,0.2,0.2,0.19999999999999998,0.08366600265340754
gpt-3.5-turbo,0.8,Minimum revenue increase,0.09,0.05,0.05,0.09999999999999999,0.054772255750516606
gpt-3.5-turbo,0.8,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.8,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.8,Potential market share,0.294,0.3,0.3,0.019999999999999962,0.008944271909999146
gpt-3.5-turbo,0.8,Potential net profit growth,0.10800000000000001,0.1,0.1,0.01999999999999999,0.010954451150103317
gpt-3.5-turbo,0.8,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.8,Strategic priority,0.3,0.5,0.5,0.5,0.2738612787525831
gpt-3.5-turbo,0.8,Talent development strategy,0.8666666666666666,0.8888888888888888,0.8888888888888888,0.11111111111111105,0.0496903994999953
gpt-3.5-turbo,0.8,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.8,Workforce increase for S&M,0.266,0.25,0.25,0.08000000000000002,0.03577708763999664
gpt-3.5-turbo,0.9,Competitive positioning,0.55,0.5,0.5,0.25,0.11180339887498948
gpt-3.5-turbo,0.9,Employee structure focus,0.0,0.0,0.0,0.0,0.0
gpt-3.5-turbo,0.9,European market revenue,0.156,0.16,0.13,0.07,0.02880972058177587
gpt-3.5-turbo,0.9,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.9,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-3.5-turbo,0.9,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,0.9,Maximum annual interest rate,0.10200000000000001,0.1,0.06,0.09,0.034928498393145956
gpt-3.5-turbo,0.9,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-3.5-turbo,0.9,Minimum ROI,0.24,0.2,0.2,0.09999999999999998,0.0547722557505166
gpt-3.5-turbo,0.9,Minimum revenue increase,0.08,0.05,0.05,0.09999999999999999,0.04472135954999579
gpt-3.5-turbo,0.9,Overall attractiveness,0.7555555555555555,0.7777777777777778,0.7777777777777778,0.11111111111111116,0.049690399499995354
gpt-3.5-turbo,0.9,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,0.9,Potential market share,0.27542,0.27,0.2571,0.0529,0.0213279628656841
gpt-3.5-turbo,0.9,Potential net profit growth,0.1092,0.1,0.1,0.025999999999999995,0.012774975538137046
gpt-3.5-turbo,0.9,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,0.9,Strategic priority,0.1,0.0,0.0,0.5,0.223606797749979
gpt-3.5-turbo,0.9,Talent development strategy,0.8666666666666666,0.8888888888888888,0.8888888888888888,0.11111111111111105,0.0496903994999953
gpt-3.5-turbo,0.9,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,0.9,Workforce increase for S&M,0.262,0.25,0.2,0.14999999999999997,0.05718391382198318
gpt-3.5-turbo,1.0,Competitive positioning,0.6666666666666666,0.75,0.75,0.25,0.14433756729740646
gpt-3.5-turbo,1.0,Employee structure focus,0.16666666666666666,0.0,0.0,0.5,0.2886751345948129
gpt-3.5-turbo,1.0,European market revenue,0.14,0.14,0.13,0.01999999999999999,0.009999999999999995
gpt-3.5-turbo,1.0,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,1.0,Funds allocation for analytics,0.4000000000000001,0.4,0.4,0.0,6.798699777552591e-17
gpt-3.5-turbo,1.0,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-3.5-turbo,1.0,Maximum annual interest rate,0.13333333333333333,0.1,0.1,0.1,0.05773502691896258
gpt-3.5-turbo,1.0,Maximum ownership percentage,0.20000000000000004,0.2,0.2,0.0,3.3993498887762956e-17
gpt-3.5-turbo,1.0,Minimum ROI,0.2833333333333334,0.25,0.2,0.2,0.10408329997330665
gpt-3.5-turbo,1.0,Minimum revenue increase,0.11953333333333334,0.15,0.0546,0.09939999999999999,0.056269470704222314
gpt-3.5-turbo,1.0,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,1.0,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-3.5-turbo,1.0,Potential market share,0.26333333333333336,0.26,0.25,0.030000000000000027,0.01527525231651948
gpt-3.5-turbo,1.0,Potential net profit growth,0.10666666666666667,0.1,0.1,0.01999999999999999,0.011547005383792509
gpt-3.5-turbo,1.0,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-3.5-turbo,1.0,Strategic priority,0.16666666666666666,0.0,0.0,0.5,0.2886751345948129
gpt-3.5-turbo,1.0,Talent development strategy,0.8888888888888888,0.8888888888888888,0.8888888888888888,0.0,0.0
gpt-3.5-turbo,1.0,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-3.5-turbo,1.0,Workforce increase for S&M,0.2733333333333334,0.25,0.24,0.09000000000000002,0.049328828623162485
gpt-4,0.0,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,0.0,Employee structure focus,0.5,0.5,0.5,0.0,0.0
gpt-4,0.0,European market revenue,0.18105263157894738,0.17,0.17,0.03,0.014867838833500562
gpt-4,0.0,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.0,Funds allocation for analytics,0.4,0.4,0.4,0.0,5.703228632848239e-17
gpt-4,0.0,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,1.1406457265696477e-16
gpt-4,0.0,Maximum annual interest rate,0.06421052631578947,0.06,0.06,0.020000000000000004,0.008377078165833912
gpt-4,0.0,Maximum ownership percentage,0.2,0.2,0.2,0.0,2.851614316424119e-17
gpt-4,0.0,Minimum ROI,0.16842105263157894,0.15,0.15,0.05000000000000002,0.024779731389167614
gpt-4,0.0,Minimum revenue increase,0.11842105263157894,0.1,0.1,0.04999999999999999,0.024779731389167597
gpt-4,0.0,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,1.1406457265696477e-16
gpt-4,0.0,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,1.1406457265696477e-16
gpt-4,0.0,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.0,Potential net profit growth,0.13,0.13,0.13,0.0,2.851614316424119e-17
gpt-4,0.0,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,0.0,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.0,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,1.1406457265696477e-16
gpt-4,0.0,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.0,Workforce increase for S&M,0.2605263157894737,0.25,0.25,0.09999999999999998,0.03153017676423057
gpt-4,0.1,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,0.1,Employee structure focus,0.5,0.5,0.5,0.0,0.0
gpt-4,0.1,European market revenue,0.18166666666666667,0.17,0.17,0.03,0.015048939771136506
gpt-4,0.1,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.1,Funds allocation for analytics,0.4,0.4,0.4,0.0,5.712050337475533e-17
gpt-4,0.1,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,1.1424100674951067e-16
gpt-4,0.1,Maximum annual interest rate,0.06333333333333332,0.06,0.06,0.020000000000000004,0.007669649888473707
gpt-4,0.1,Maximum ownership percentage,0.2,0.2,0.2,0.0,2.856025168737767e-17
gpt-4,0.1,Minimum ROI,0.19444444444444445,0.2,0.2,0.05000000000000002,0.01616904166908887
gpt-4,0.1,Minimum revenue increase,0.13055555555555556,0.1,0.1,0.1,0.03887721580176147
gpt-4,0.1,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,1.1424100674951067e-16
gpt-4,0.1,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,1.1424100674951067e-16
gpt-4,0.1,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.1,Potential net profit growth,0.13,0.13,0.13,0.0,0.0
gpt-4,0.1,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,0.1,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.1,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,1.1424100674951067e-16
gpt-4,0.1,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.1,Workforce increase for S&M,0.25,0.25,0.25,0.0,0.0
gpt-4,0.2,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,0.2,Employee structure focus,0.375,0.5,0.5,0.5,0.22360679774997896
gpt-4,0.2,European market revenue,0.185,0.185,0.17,0.03,0.015491933384829668
gpt-4,0.2,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.2,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-4,0.2,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-4,0.2,Maximum annual interest rate,0.06,0.06,0.06,0.0,0.0
gpt-4,0.2,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-4,0.2,Minimum ROI,0.16875,0.15,0.15,0.05000000000000002,0.02500000000000001
gpt-4,0.2,Minimum revenue increase,0.125,0.125,0.1,0.04999999999999999,0.025819888974716106
gpt-4,0.2,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.2,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.2,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.2,Potential net profit growth,0.13,0.13,0.13,0.0,0.0
gpt-4,0.2,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,0.2,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.2,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.2,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.2,Workforce increase for S&M,0.2625,0.25,0.25,0.09999999999999998,0.03415650255319865
gpt-4,0.3,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,0.3,Employee structure focus,0.5,0.5,0.5,0.0,0.0
gpt-4,0.3,European market revenue,0.1925,0.2,0.2,0.03,0.013416407864998738
gpt-4,0.3,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.3,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-4,0.3,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-4,0.3,Maximum annual interest rate,0.0675,0.06,0.06,0.020000000000000004,0.010000000000000002
gpt-4,0.3,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-4,0.3,Minimum ROI,0.18125,0.2,0.2,0.05000000000000002,0.02500000000000001
gpt-4,0.3,Minimum revenue increase,0.15,0.15,0.15,0.1,0.03651483716701108
gpt-4,0.3,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.3,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.3,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.3,Potential net profit growth,0.13,0.13,0.13,0.0,0.0
gpt-4,0.3,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,0.3,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.3,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.3,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.3,Workforce increase for S&M,0.2833333333333333,0.25,0.25,0.09999999999999998,0.049236596391733084
gpt-4,0.4,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,0.4,Employee structure focus,0.5,0.5,0.5,0.0,0.0
gpt-4,0.4,European market revenue,0.18875,0.2,0.2,0.03,0.015
gpt-4,0.4,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.4,Funds allocation for analytics,0.4,0.4,0.4,0.0,0.0
gpt-4,0.4,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-4,0.4,Maximum annual interest rate,0.0625,0.06,0.06,0.020000000000000004,0.006831300510639734
gpt-4,0.4,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-4,0.4,Minimum ROI,0.2,0.2,0.2,0.1,0.03651483716701108
gpt-4,0.4,Minimum revenue increase,0.12,0.10500000000000001,0.1,0.04999999999999999,0.024221202832779926
gpt-4,0.4,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.4,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.4,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.4,Potential net profit growth,0.13,0.13,0.13,0.0,0.0
gpt-4,0.4,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,0.4,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.4,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.4,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.4,Workforce increase for S&M,0.3,0.3,0.25,0.09999999999999998,0.05163977794943221
gpt-4,0.5,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,0.5,Employee structure focus,0.42857142857142855,0.5,0.5,0.5,0.18898223650461363
gpt-4,0.5,European market revenue,0.18285714285714286,0.17,0.17,0.03,0.016035674514745465
gpt-4,0.5,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.5,Funds allocation for analytics,0.39285714285714285,0.4,0.4,0.050000000000000044,0.018898223650461374
gpt-4,0.5,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-4,0.5,Maximum annual interest rate,0.06,0.06,0.06,0.0,0.0
gpt-4,0.5,Maximum ownership percentage,0.2,0.2,0.2,0.0,2.997944808332385e-17
gpt-4,0.5,Minimum ROI,0.16428571428571428,0.15,0.15,0.05000000000000002,0.02439750182371334
gpt-4,0.5,Minimum revenue increase,0.1285714285714286,0.1,0.1,0.1,0.039339789623472156
gpt-4,0.5,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.5,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.5,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.5,Potential net profit growth,0.13142857142857142,0.13,0.13,0.010000000000000009,0.0037796447300922757
gpt-4,0.5,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,0.5,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.5,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.5,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.5,Workforce increase for S&M,0.3,0.25,0.25,0.15000000000000002,0.06454972243679027
gpt-4,0.6,Competitive positioning,0.7142857142857143,0.75,0.75,0.25,0.09449111825230683
gpt-4,0.6,Employee structure focus,0.42857142857142855,0.5,0.5,0.5,0.18898223650461363
gpt-4,0.6,European market revenue,0.17857142857142858,0.17,0.17,0.03,0.014638501094227997
gpt-4,0.6,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.6,Funds allocation for analytics,0.4,0.4,0.4,0.0,5.99588961666477e-17
gpt-4,0.6,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-4,0.6,Maximum annual interest rate,0.06714285714285714,0.06,0.06,0.020000000000000004,0.00951189731211342
gpt-4,0.6,Maximum ownership percentage,0.2,0.2,0.2,0.0,2.997944808332385e-17
gpt-4,0.6,Minimum ROI,0.17142857142857143,0.15,0.15,0.05000000000000002,0.026726124191242446
gpt-4,0.6,Minimum revenue increase,0.12571428571428572,0.1,0.1,0.12000000000000001,0.05126959555693247
gpt-4,0.6,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.6,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.6,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.6,Potential net profit growth,0.13,0.13,0.13,0.0,0.0
gpt-4,0.6,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,0.6,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.6,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.6,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.6,Workforce increase for S&M,0.2833333333333333,0.25,0.25,0.09999999999999998,0.05163977794943221
gpt-4,0.7,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,0.7,Employee structure focus,0.35714285714285715,0.5,0.5,0.5,0.24397501823713333
gpt-4,0.7,European market revenue,0.17857142857142858,0.17,0.17,0.03,0.014638501094227999
gpt-4,0.7,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.7,Funds allocation for analytics,0.39285714285714285,0.4,0.4,0.050000000000000044,0.018898223650461374
gpt-4,0.7,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-4,0.7,Maximum annual interest rate,0.07142857142857142,0.08,0.08,0.020000000000000004,0.010690449676496978
gpt-4,0.7,Maximum ownership percentage,0.2,0.2,0.2,0.0,2.997944808332385e-17
gpt-4,0.7,Minimum ROI,0.2,0.2,0.2,0.0,2.997944808332385e-17
gpt-4,0.7,Minimum revenue increase,0.15,0.15,0.15,0.1,0.040824829046386304
gpt-4,0.7,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.7,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.7,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.7,Potential net profit growth,0.13,0.13,0.13,0.0,0.0
gpt-4,0.7,Product focus,0.8571428571428571,1.0,1.0,1.0,0.37796447300922725
gpt-4,0.7,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.7,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.7,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.7,Workforce increase for S&M,0.3,0.25,0.25,0.15000000000000002,0.07745966692414835
gpt-4,0.8,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,0.8,Employee structure focus,0.42857142857142855,0.5,0.5,0.5,0.18898223650461363
gpt-4,0.8,European market revenue,0.17714285714285713,0.17,0.17,0.04000000000000001,0.016035674514745468
gpt-4,0.8,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.8,Funds allocation for analytics,0.38571428571428573,0.4,0.4,0.050000000000000044,0.02439750182371335
gpt-4,0.8,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-4,0.8,Maximum annual interest rate,0.06571428571428571,0.06,0.06,0.020000000000000004,0.009759000729485334
gpt-4,0.8,Maximum ownership percentage,0.2,0.2,0.2,0.0,2.997944808332385e-17
gpt-4,0.8,Minimum ROI,0.15,0.15,0.15,0.1,0.040824829046386304
gpt-4,0.8,Minimum revenue increase,0.13285714285714287,0.11,0.1,0.1,0.046445052020025315
gpt-4,0.8,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.8,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.8,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.8,Potential net profit growth,0.13142857142857142,0.13,0.13,0.010000000000000009,0.0037796447300922757
gpt-4,0.8,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,0.8,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.8,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,0.8,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.8,Workforce increase for S&M,0.32142857142857145,0.35,0.35,0.09999999999999998,0.04879500364742665
gpt-4,0.9,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,0.9,Employee structure focus,0.2692307692307692,0.5,0.5,0.5,0.25943726083138546
gpt-4,0.9,European market revenue,0.17538461538461542,0.17,0.17,0.04000000000000001,0.014500221041639687
gpt-4,0.9,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,0.9,Funds allocation for analytics,0.3807692307692308,0.4,0.4,0.050000000000000044,0.025318484177091687
gpt-4,0.9,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-4,0.9,Maximum annual interest rate,0.07230769230769231,0.08,0.08,0.020000000000000004,0.010127393670836668
gpt-4,0.9,Maximum ownership percentage,0.2,0.2,0.2,0.0,2.888891902733299e-17
gpt-4,0.9,Minimum ROI,0.2,0.2,0.2,0.1,0.03535533905932738
gpt-4,0.9,Minimum revenue increase,0.13076923076923078,0.1,0.1,0.1,0.048038446141526144
gpt-4,0.9,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,1.1555567610933196e-16
gpt-4,0.9,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,1.1555567610933196e-16
gpt-4,0.9,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,0.9,Potential net profit growth,0.13,0.13,0.13,0.0,5.777783805466598e-17
gpt-4,0.9,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,0.9,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,0.9,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,1.1555567610933196e-16
gpt-4,0.9,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,0.9,Workforce increase for S&M,0.28846153846153844,0.25,0.25,0.09999999999999998,0.05063696835418331
gpt-4,1.0,Competitive positioning,0.75,0.75,0.75,0.0,0.0
gpt-4,1.0,Employee structure focus,0.3333333333333333,0.5,0.5,0.5,0.25
gpt-4,1.0,European market revenue,0.18000000000000002,0.17,0.17,0.03,0.015
gpt-4,1.0,Funding options,1.0,1.0,1.0,0.0,0.0
gpt-4,1.0,Funds allocation for analytics,0.38333333333333336,0.4,0.4,0.050000000000000044,0.025000000000000026
gpt-4,1.0,Growth strategy,0.6666666666666666,0.6666666666666666,0.6666666666666666,0.0,0.0
gpt-4,1.0,Maximum annual interest rate,0.07,0.08,0.08,0.03,0.015
gpt-4,1.0,Maximum ownership percentage,0.2,0.2,0.2,0.0,0.0
gpt-4,1.0,Minimum ROI,0.18333333333333335,0.2,0.2,0.05000000000000002,0.02500000000000001
gpt-4,1.0,Minimum revenue increase,0.21666666666666667,0.2,0.15,0.15,0.06614378277661476
gpt-4,1.0,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,1.0,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,1.0,Potential market share,0.25,0.25,0.25,0.0,0.0
gpt-4,1.0,Potential net profit growth,0.13333333333333336,0.13,0.13,0.010000000000000009,0.0050000000000000044
gpt-4,1.0,Product focus,1.0,1.0,1.0,0.0,0.0
gpt-4,1.0,Strategic priority,0.0,0.0,0.0,0.0,0.0
gpt-4,1.0,Talent development strategy,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.0,0.0
gpt-4,1.0,TeleHealth platform success,0.75,0.75,0.75,0.0,0.0
gpt-4,1.0,Workforce increase for S&M,0.30000000000000004,0.25,0.25,0.15000000000000002,0.07500000000000001
Human,0.3,Competitive positioning,0.6666666666666666,0.75,0.75,0.25,0.12909944487358055
Human,0.3,Employee structure focus,0.25,0.25,0.0,0.5,0.27386127875258304
Human,0.3,European market revenue,0.1555,0.161,0.1,0.1,0.04196427051671458
Human,0.3,Funding options,0.8333333333333334,1.0,1.0,1.0,0.408248290463863
Human,0.3,Funds allocation for analytics,0.275,0.275,0.25,0.04999999999999999,0.03535533905932737
Human,0.3,Growth strategy,0.5555555555555555,0.6666666666666666,0.6666666666666666,0.3333333333333333,0.17213259316477406
Human,0.3,Maximum annual interest rate,0.078,0.07,0.04,0.07999999999999999,0.03193743884534263
Human,0.3,Maximum ownership percentage,0.17400000000000002,0.2,0.2,0.1,0.0433589667773576
Human,0.3,Minimum ROI,0.164,0.14,0.12,0.12,0.05366563145999495
Human,0.3,Minimum revenue increase,0.19,0.18,0.1,0.19999999999999998,0.09591663046625439
Human,0.3,Overall attractiveness,0.6666666666666666,0.7222222222222222,0.7777777777777778,0.4444444444444445,0.17213259316477408
Human,0.3,Overall performance,0.6851851851851851,0.7222222222222222,0.7777777777777778,0.6666666666666667,0.22680460581325723
Human,0.3,Potential market share,0.238,0.25,0.25,0.04999999999999999,0.021679483388678797
Human,0.3,Potential net profit growth,0.1355,0.135,0.12,0.032,0.017916472867168916
Human,0.3,Product focus,0.5,0.5,0.0,1.0,0.5477225575051661
Human,0.3,Strategic priority,0.4166666666666667,0.25,0.0,1.0,0.4915960401250875
Human,0.3,Talent development strategy,0.6296296296296297,0.6111111111111112,0.5555555555555556,0.5555555555555556,0.19457667461575845
Human,0.3,TeleHealth platform success,0.5833333333333334,0.625,0.75,0.5,0.2041241452319315
Human,0.3,Workforce increase for S&M,0.11333333333333334,0.125,0.0,0.2,0.07788880963698615
Human,0.5,Competitive positioning,0.6666666666666666,0.75,0.75,0.5,0.2041241452319315
Human,0.5,Employee structure focus,0.3333333333333333,0.5,0.5,0.5,0.25819888974716115
Human,0.5,European market revenue,0.16999999999999998,0.15,0.15,0.05000000000000002,0.027386127875258313
Human,0.5,Funding options,0.8333333333333334,1.0,1.0,1.0,0.408248290463863
Human,0.5,Funds allocation for analytics,0.19,0.2,0.2,0.15,0.05477225575051661
Human,0.5,Growth strategy,0.611111111111111,0.8333333333333333,1.0,1.0,0.4906533814626582
Human,0.5,Maximum annual interest rate,0.05833333333333333,0.052500000000000005,0.05,0.04,0.015705625319186328
Human,0.5,Maximum ownership percentage,0.18611666666666668,0.2,0.2,0.15,0.04990472589511605
Human,0.5,Minimum ROI,0.11839999999999999,0.1,0.012,0.22799999999999998,0.09905957803261631
Human,0.5,Minimum revenue increase,0.12333333333333334,0.11,0.1,0.1,0.038815804341359034
Human,0.5,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.33333333333333337,0.12171612389003693
Human,0.5,Overall performance,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.2222222222222222,0.07027283689263066
Human,0.5,Potential market share,0.2816666666666667,0.265,0.25,0.15999999999999998,0.06242328625334191
Human,0.5,Potential net profit growth,0.17200000000000001,0.15,0.15,0.16999999999999998,0.06870225614927067
Human,0.5,Product focus,0.8333333333333334,1.0,1.0,1.0,0.408248290463863
Human,0.5,Strategic priority,0.25,0.0,0.0,1.0,0.4183300132670378
Human,0.5,Talent development strategy,0.7592592592592592,0.7777777777777778,0.7777777777777778,0.33333333333333326,0.10924356447224165
Human,0.5,TeleHealth platform success,0.75,0.75,0.75,0.5,0.15811388300841897
Human,0.5,Workforce increase for S&M,0.21666666666666667,0.2,0.15,0.15,0.07637626158259733
Human,0.6,Competitive positioning,0.5625,0.5,0.5,0.75,0.2140872096444188
Human,0.6,Employee structure focus,0.3125,0.5,0.5,1.0,0.30956959368344517
Human,0.6,European market revenue,0.17731333333333332,0.16,0.15,0.15500000000000003,0.04682155893338432
Human,0.6,Funding options,0.71875,1.0,1.0,1.0,0.4460474563690878
Human,0.6,Funds allocation for analytics,0.2538333333333333,0.268,0.3,0.18,0.05610028898537353
Human,0.6,Growth strategy,0.7083333333333333,0.6666666666666666,0.6666666666666666,1.0,0.3191423692521127
Human,0.6,Maximum annual interest rate,0.05433333333333334,0.045,0.04,0.09,0.024265397664359922
Human,0.6,Maximum ownership percentage,0.18225,0.2,0.2,0.25,0.05288288948232689
Human,0.6,Minimum ROI,0.13692307692307693,0.12,0.1,0.31,0.08189267523051287
Human,0.6,Minimum revenue increase,0.12866666666666665,0.1,0.1,0.22,0.055144830954064784
Human,0.6,Overall attractiveness,0.6666666666666666,0.7777777777777778,0.7777777777777778,0.6666666666666667,0.19029974190615007
Human,0.6,Overall performance,0.6805555555555556,0.7777777777777778,0.7777777777777778,0.5555555555555556,0.17153386928754683
Human,0.6,Potential market share,0.26135714285714284,0.26,0.25,0.26,0.06750225881446445
Human,0.6,Potential net profit growth,0.12964285714285714,0.10700000000000001,0.1,0.37499999999999994,0.0878404209942072
Human,0.6,Product focus,0.625,1.0,1.0,1.0,0.5
Human,0.6,Strategic priority,0.1875,0.0,0.0,1.0,0.35939764421413045
Human,0.6,Talent development strategy,0.7291666666666666,0.6666666666666666,0.5555555555555556,0.4444444444444444,0.16212960318970954
Human,0.6,TeleHealth platform success,0.6875,0.75,0.75,0.75,0.2327373340628157
Human,0.6,Workforce increase for S&M,0.17153846153846153,0.15,0.1,0.23,0.07872379498878275
Human,0.7,Competitive positioning,0.6923076923076923,0.75,0.75,0.5,0.14978617237881953
Human,0.7,Employee structure focus,0.23076923076923078,0.0,0.0,1.0,0.3301126458867624
Human,0.7,European market revenue,0.21424545454545454,0.21,0.3,0.19999999999999998,0.06631487561077624
Human,0.7,Funding options,0.9615384615384616,1.0,1.0,0.5,0.1386750490563073
Human,0.7,Funds allocation for analytics,0.23142857142857146,0.2,0.2,0.24999999999999997,0.0880205603686948
Human,0.7,Growth strategy,0.8205128205128205,0.6666666666666666,0.6666666666666666,0.33333333333333337,0.1729581738875903
Human,0.7,Maximum annual interest rate,0.07615384615384616,0.05,0.04,0.29,0.07274824872330393
Human,0.7,Maximum ownership percentage,0.12916666666666668,0.155,0.1,0.18000000000000002,0.054793551932078036
Human,0.7,Minimum ROI,0.158,0.15,0.15,0.31,0.09354737361952559
Human,0.7,Minimum revenue increase,0.1725,0.175,0.2,0.19999999999999998,0.06383572667401852
Human,0.7,Overall attractiveness,0.7435897435897435,0.7777777777777778,0.7777777777777778,0.5555555555555556,0.15963316605571012
Human,0.7,Overall performance,0.7606837606837608,0.7777777777777778,0.7777777777777778,0.33333333333333326,0.09985744825254633
Human,0.7,Potential market share,0.256,0.25,0.2,0.15999999999999998,0.046546164767308745
Human,0.7,Potential net profit growth,0.10458333333333332,0.1275,0.15,0.15,0.05524566347989073
Human,0.7,Product focus,0.7692307692307693,1.0,1.0,1.0,0.4385290096535146
Human,0.7,Strategic priority,0.46153846153846156,0.5,0.0,1.0,0.47703679372151425
Human,0.7,Talent development strategy,0.7435897435897435,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.20480149671026374
Human,0.7,TeleHealth platform success,0.75,0.75,0.75,0.5,0.10206207261596575
Human,0.7,Workforce increase for S&M,0.170625,0.175,0.2,0.27,0.0832568101032668
Human,0.8,Competitive positioning,0.6,0.5,0.5,0.25,0.13693063937629152
Human,0.8,Employee structure focus,0.2,0.0,0.0,0.5,0.2738612787525831
Human,0.8,European market revenue,0.16094,0.163,0.11,0.12499999999999999,0.047630011547342706
Human,0.8,Funding options,0.7,0.5,0.5,0.5,0.27386127875258304
Human,0.8,Funds allocation for analytics,0.26666666666666666,0.3,0.15,0.19999999999999998,0.10408329997330663
Human,0.8,Growth strategy,0.7333333333333333,0.6666666666666666,0.6666666666666666,0.33333333333333337,0.149071198499986
Human,0.8,Maximum annual interest rate,0.06999999999999999,0.06,0.04,0.07999999999999999,0.034641016151377546
Human,0.8,Maximum ownership percentage,0.15988,0.166,0.15,0.01670000000000002,0.009023691040810305
Human,0.8,Minimum ROI,0.2334,0.267,0.15,0.15,0.0773162337416923
Human,0.8,Minimum revenue increase,0.11574999999999999,0.125,0.05,0.113,0.05156468429716861
Human,0.8,Overall attractiveness,0.7777777777777778,0.7777777777777778,0.7777777777777778,0.2222222222222222,0.07856742013183861
Human,0.8,Overall performance,0.6444444444444445,0.6666666666666666,0.6666666666666666,0.33333333333333337,0.12171612389003693
Human,0.8,Potential market share,0.274,0.28,0.23,0.1,0.04393176527297759
Human,0.8,Potential net profit growth,0.15,0.13,0.09,0.14,0.06204836822995429
Human,0.8,Product focus,0.8,1.0,1.0,1.0,0.4472135954999579
Human,0.8,Strategic priority,0.5,0.5,0.0,1.0,0.5
Human,0.8,Talent development strategy,0.6888888888888889,0.6666666666666666,0.6666666666666666,0.4444444444444444,0.16480441082434805
Human,0.8,TeleHealth platform success,0.6,0.75,0.75,0.5,0.22360679774997896
Human,0.8,Workforce increase for S&M,0.22,0.2,0.1,0.26,0.13114877048604
Human,0.9,Competitive positioning,0.6,0.5,0.5,0.25,0.13693063937629152
Human,0.9,Employee structure focus,0.5,0.5,0.5,0.0,0.0
Human,0.9,European market revenue,0.165,0.18,0.07,0.16,0.0695221787153807
Human,0.9,Funding options,0.6,0.5,0.5,1.0,0.4183300132670378
Human,0.9,Funds allocation for analytics,0.32499999999999996,0.32499999999999996,0.3,0.04999999999999999,0.03535533905932737
Human,0.9,Growth strategy,0.9333333333333332,1.0,1.0,0.33333333333333337,0.149071198499986
Human,0.9,Maximum annual interest rate,0.07025,0.060000000000000005,0.040999999999999995,0.079,0.03531170721823949
Human,0.9,Maximum ownership percentage,0.14425,0.155,0.1,0.06699999999999998,0.030313638294778577
Human,0.9,Minimum ROI,0.17333333333333334,0.12,0.1,0.19999999999999998,0.11015141094572203
Human,0.9,Minimum revenue increase,0.2,0.2,0.15,0.1,0.07071067811865477
Human,0.9,Overall attractiveness,0.711111111111111,0.7777777777777778,0.7777777777777778,0.4444444444444444,0.16850834320114558
Human,0.9,Overall performance,0.6222222222222222,0.5555555555555556,0.4444444444444444,0.4444444444444444,0.20184335693983277
Human,0.9,Potential market share,0.305,0.3,0.3,0.020000000000000018,0.010000000000000009
Human,0.9,Potential net profit growth,0.1345,0.134,0.12,0.03,0.01268857754044952
Human,0.9,Product focus,0.6,1.0,1.0,1.0,0.5477225575051662
Human,0.9,Strategic priority,0.4,0.0,0.0,1.0,0.5477225575051662
Human,0.9,Talent development strategy,0.8,0.7777777777777778,0.7777777777777778,0.2222222222222222,0.09296222517045283
Human,0.9,TeleHealth platform success,0.8,0.75,0.75,0.5,0.2091650066335189
Human,0.9,Workforce increase for S&M,0.15,0.15,0.1,0.1,0.05
Human,1.0,Competitive positioning,1.0,1.0,1.0,0.0,0.0
Human,1.0,Employee structure focus,0.0,0.0,0.0,0.0,0.0
Human,1.0,Funding options,0.0,0.0,0.0,0.0,0.0
Human,1.0,Funds allocation for analytics,0.285,0.285,0.285,0.0,0.0
Human,1.0,Growth strategy,1.0,1.0,1.0,0.0,0.0
Human,1.0,Maximum annual interest rate,0.04,0.04,0.04,0.0,0.0
Human,1.0,Maximum ownership percentage,0.1,0.1,0.1,0.0,0.0
Human,1.0,Minimum ROI,0.34,0.34,0.34,0.0,0.0
Human,1.0,Minimum revenue increase,0.1,0.1,0.1,0.0,0.0
Human,1.0,Overall attractiveness,1.0,1.0,1.0,0.0,0.0
Human,1.0,Overall performance,1.0,1.0,1.0,0.0,0.0
Human,1.0,Potential market share,0.2,0.2,0.2,0.0,0.0
Human,1.0,Potential net profit growth,0.12,0.12,0.12,0.0,0.0
Human,1.0,Product focus,0.0,0.0,0.0,0.0,0.0
Human,1.0,Strategic priority,0.0,0.0,0.0,0.0,0.0
Human,1.0,Talent development strategy,1.0,1.0,1.0,0.0,0.0
Human,1.0,TeleHealth platform success,1.0,1.0,1.0,0.0,0.0
Human,1.0,Workforce increase for S&M,0.0,0.0,0.0,0.0,0.0
